Rutledge v. Pharmaceutical Care Management Assn.
In brief
Arkansas won on the main question: ERISA does not override Act 900, and the Court sent the case back to the Eighth Circuit (remanded).
- Where it stands
- Decided
Decided 8-0 · December 10, 2020 · Opinion by Justice Sotomayor
- What it’s about
- The Supreme Court overturned the Eighth Circuit’s ruling and sent the case back to the lower court (reversed and remanded), deciding that Arkansas’s Act 900 is not preempted (overridden) by ERISA.
- Who it affects
- The decision leaves Act 900 standing against this ERISA challenge. Its updated reimbursement-list requirement and pharmacy appeal process are not wiped out by ERISA.
Summary: written with AI from the case record.
What it's about
The law regulates how pharmacy benefit managers (PBMs) reimburse pharmacies for prescription drugs, and the Pharmaceutical Care Management Association challenged it.
The case was part of a broader conflict between federal employee-benefit rules and similar pharmacy-reimbursement laws in many states.
Question presented
Whether the Eighth Circuit erred in holding that Arkansas's statute regulating PBMs' drug-reimbursement rates, which is similar to laws enacted by a substantial majority of States, is preempted by ERISA, in contravention of this Court's precedent that ERISA does not preempt rate regulation.
What the Court decided
Holding
Arkansas’ Act 900 is not pre-empted by ERISA. 891 F. 3d 1109, reversed and remanded.
- Result
- Reversed
The vote
What's next
The Supreme Court sent the case back to the Eighth Circuit (remanded). That court will continue proceedings under the Supreme Court’s ruling.
Documents
Docket activity
New analysis added
AI analysis generated: Impact Analysis
AI analysis generated: Opinion Summary
Case data updated: summary, question_presented, generation_metadata
New analysis added
Show 7 moreShow fewer
AI analysis generated: Case Briefing
AI analysis generated: Decision Record
New analysis added
Opinion added: opinion
Brief added: Petition
Court Order added: Lower Court Orders/Opinions
Brief added: Questions Presented
More questions
- What did Rutledge v. Pharmaceutical Care Management Assn. decide about Act 900?
- The Court ruled that ERISA does not override Act 900. It overturned the Eighth Circuit’s ruling and sent the case back to that court (remanded).
- What does the ruling mean for Arkansas’s pharmacies?
- ERISA does not override Act 900’s updated reimbursement lists. The law requires an appeal process when pharmacies receive less than what they paid for the drugs.
- Who signed on to the Supreme Court’s opinion in Rutledge?
- The vote was 8-0, and Justice Sonia Sotomayor wrote the opinion. All participating justices signed on to it; Justice Clarence Thomas wrote separately, and Justice Barrett did not participate.
Sources
Primary materials plus reporting. Best-effort analysis: this explainer relies on a mix of primary materials and trusted secondary sources. Official filings and opinions remain authoritative.